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Abstract
Background: Alternative splicing (AS) is a major source of variability in the transcriptome of eukaryotes. There is an
increasing interest in its role in different pathologies. Before sequencing technology appeared, AS was measured
with specific arrays. However, these arrays did not perform well in the detection of AS events and provided very
large false discovery rates (FDR). Recently the Human Transcriptome Array 2.0 (HTA 2.0) has been deployed. It
includes junction probes. However, the interpretation software provided by its vendor (TAC 3.0) does not fully
exploit its potential (does not study jointly the exons and junctions involved in a splicing event) and can only be
applied to case–control studies. New statistical algorithms and software must be developed in order to exploit the
HTA 2.0 array for event detection.
Results: We have developed EventPointer, an R package (built under the aroma.affymetrix framework) to search
and analyze Alternative Splicing events using HTA 2.0 arrays. This software uses a linear model that broadens its
application from plain case–control studies to complex experimental designs. Given the CEL files and the design
and contrast matrices, the software retrieves a list of all the detected events indicating: 1) the type of event (exon
cassette, alternative 3′, etc.), 2) its fold change and its statistical significance, and 3) the potential protein domains
affected by the AS events and the statistical significance of the possible enrichment.
Our tests have shown that EventPointer has an extremely low FDR value (only 1 false positive within the tested
top-200 events). This software is publicly available and it has been uploaded to GitHub.
Conclusions: This software empowers the HTA 2.0 arrays for AS event detection as an alternative to RNA-seq:
simplifying considerably the required analysis, speeding it up and reducing the required computational power.
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Background
Alternative Splicing (AS) has been shown to be a key
factor in cellular processes such as development and
differentiation as well as in different pathologies, in-
cluding cancer [1–3]. AS has been studied using Exon
arrays and, more recently, using RNA-seq and junc-
tion arrays [4].
The first array that made use of junction probes was
based on Agilent technology and included approximately
125,000 junction probes, but lacked exon probes [5].
These were included in a later version of the array [6].
In 2010, Oryzon Genomics, in collaboration with our
group, introduced an array based on Agilent technology,
covering 7,958 genes with a total number of 115,318
exon probes and 105,141 junction probes [7]. This new
array made use of a massive number of control probes
(as much as 20 % of the array) to ensure the proper
normalization of the measurements.
In 2008, Affymetrix presented the Human Junction
Array (HJAY). It was their first experimental array with
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exon and junction probes [8]. This microarray included
approximately 6 million probes, comprising ~315,000
exons and ~260,000 junctions. Each exon and junction
was interrogated by 8 different probes. The probes of
this array were selected using RefSeq, ExonWalk and
Ensembl annotations. Two years earlier, ExonHit intro-
duced the Splicearray, also using the Affymetrix technol-
ogy (although they also provide now a version using
Agilent technology). However, the use of Exonhit arrays
is not as widespread as the use of standard ones from
Agilent or Affymetrix.
In 2011, Affymetrix, together with Stanford Univer-
sity, designed the custom Glue Grant Human Tran-
scriptome Array (GG-H array) [4]. And in 2013,
Affymetrix launched the GeneChip® Human Transcrip-
tome Array 2.0 (HTA 2.0), a more up to date catalogue of
the HJAY and GG-H arrays. The HTA 2.0 array interro-
gates a total of 1,048,904 exons or exon clusters with
more than 6.3 million probes (approximately 10 probes
per exon) and more than 339,000 exon-exon junctions
with more than 1.3 million probes (around 4 probes per
junction).
In a previous work [9], we developed an algorithm to
detect AS cassette events. It was applied to both the
HJAY and the Oryzon arrays. HJAY array clearly outper-
formed the other platform and had a validation rate for
top-ranked events of nearly 100 %. The results proved
that the Affymetrix platform is a good option to detect
AS events. The main problem of this array is that it was
unsupported upon their release.
Only the Transcriptome Analysis Console (TAC) 3.0
software offered by Affymetrix and AltAnalyze [10] are
the available options to analyze HTA 2.0 and HJAY ar-
rays. FIRMA [11], using CDFs generated by Brainarray
[12], can be applied to extract and summarize exon ex-
pression but the junction probes would be missing from
this analysis pipeline.
The main drawback of the TAC and FIRMA approaches,
is that neither of them combines the information provided
by the junction probes with the corresponding exon
probes in the event under study. For example, in the de-
tection of a cassette event, it is not sufficient to detect the
altered expression values of exon probes. In addition to
that, the flanking junctions must behave coherently and
the skipped junction must have a negative correlation. A
similar argument can be made for other AS events. On
the other hand, AltAnalyze using the ASPIRE algorithm
[13] combines the information of two probesets to get a
figure of merit for each event. For example, in a cassette
exon, AltAnalyze would provide three figures of merit:
one corresponding to the probeset of the exon and the
junction that skips it and two more combining the flank-
ing junctions with the junction that skips the exon. Even
though, this approach is intrinsically better, it would be
still desirable to have a single figure of merit per event.
There is an algorithm (MADS+) developed to exploit
combined information from exons and junctions [14].
However, its development has been discontinued and it
cannot be applied to the HTA 2.0 platform. Furthermore,
most of the algorithms developed to detect AS events
(including MADS+) are limited to the analysis of case–
control studies. Its extension to more complex experimen-
tal designs, such as case–control studies with paired
samples or time-course studies, is non-trivial.
Here, we present EventPointer, an algorithm to detect
AS events using the HTA 2.0 platform. It can be applied
to any experiment using appropriately configured design
and contrast matrices. EventPointer is based on the
limma framework in Bioconductor [15].
Results
Implementation
Since EventPointer is described in-depth in the Methods
section, here we briefly describe its main characteristics.
Using Affymetrix junction arrays (the software accepts
either HJAY and HTA 2.0), after mapping the probes
against the Ensembl transcriptome (Ensembl v. 74) [16],
the splicing graph for each gene is generated and Event-
Pointer identifies and classifies the different AS events
that can be detected with these arrays. The different
classes are alternative 3′, alternative 5′, alternative first
exon, alternative last exon, cassette exon, retained in-
tron, mutually exclusive exons and complex events
(none of the above). These steps are specific for the
arrays and do not need to be repeated for each ex-
periment. The output of this pipeline is a CDF file
that groups the probes into probesets that reflect the
splicing events. These different steps are depicted in
Figs. 1 and 2.
For each experiment, the output of the hybridization
(i.e. the CEL files returned by the scanner) must be sum-
marized using any standard pipeline (in our case, RMA).
Following probeset summarization (according to the pre-
viously prepared CDF file), EventPointer uses the provided
design and contrast matrices to compute the statistical
significance of AS events. By construction, the AS events
can always be validated using standard PCR with at most
three primers. We describe here the results of applying
the EventPointer algorithm to the HTA 2.0 arrays on an
experiment with 27 samples.
The R package EventPointer is available for download
at Github. It includes the CDF file needed for aroma.af-
fymetrix pre-processing pipeline and the necessary func-
tions to obtain the statistical results.
EventPointer also enables visualization using IGV.
EventPointer generates an output file that can be loaded
to IGV to display the events (the reference and both
paths) as well as the location of the probes for each of
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the paths. Figure 3 includes a screen capture of an event
displayed in IGV.
Within the vignettes that accompany EventPointer
we have included some secondary analyses (clustering
and functional enrichment analysis of the identified
targets) that illustrates the potential of the provided
tools.
Mapping annotations
The number of events that can be theoretically detected
by EventPointer for the HTA 2.0 and HJAY arrays are
70,886 and 37,069, respectively. Figure 4 shows the num-
ber of events using the different canonical categories.
As Fig. 4 shows, HTA 2.0 includes more splicing
events than HJAY for all event types. The majority of
Fig. 1 Overview of EventPointer. a Using as input a reference transcriptome (Ensembl), the probes of the array are mapped against it, b the splicing
graph is created. c Using the splicing graph, EventPointer detects every possible event by defining common nodes and edges (Reference Path) and
two alternative paths (P1 and P2). d These events are classified into the canonical splicing categories. e Finally, for a specific experiment and using the
design matrix of the experiment and an auxiliary event matrix, the statistical significance of each gene is computed using the limma framework. Steps
(a-d) are specific of the array and thus, is only necessary to rerun them if the reference transcriptome is changed. Step E) must be performed for
each experiment
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Fig. 2 Description of the detection of events from the splicing graph using EventPointer. The SG is extended (every single node is splitted into
two to ensure that the probesets are mapped only to edges) and corrected to force. The splicing graph is interrogated to find eventsand
detected events are classified into one of the three possible groups (event a is a cassette and b an alternative last event). Each of these groups
are further subdivided into the different event types checking the length of the junctions
Fig. 3 Visualization of EventPointer prediction in IGV. Image generated by EventPointer as displayed in IGV
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detected event types correspond to complex events (i.e.
events that cannot be included in any of the standard
categories). As the transcriptome annotation improves,
it also becomes more complex. Previously we developed
ExonPointer, an algorithm to detect AS cassette exon
events [17]. EventPointer extends ExonPointer more
than ten-fold, taking the 6515 cassette events in the
HTA 2.0 array to more than 70,000 splicing events of
any type. In addition to that, EventPointer provides a
more rigorous definition of a cassette event and can be
run on the HTA 2.0 arrays. We will focus on the results
with HTA 2.0 since it interrogates more exons and junc-
tions than HJAY and is a more recent and stable devel-
opment of Affymetrix.
Transcriptome data
The performance of the developed algorithms was tested
in an experiment where the splicing factor SRSF1 was
knocked down using siRNA on the A549 lung adenocar-
cinoma cell line. This cell line was obtained from the
American Type Culture Collection (ATCC). The experi-
ment included three conditions: cells treated only with
the vehicle of the transfection (Lipofectamine 2000, Invi-
trogen), cells treated with scramble siRNA (i.e. a se-
quence that will not lead to the specific degradation of
any cellular mRNA) and cells transfected with a siRNA
that targets SRSF1. Each condition had three biological
replicates that, in turn, were hybridized three times (9
hybridizations). The efficiency of this inhibition has been
stated elsewhere [9].
The splicing factor SRSF1 [18] has a pleiotropic effect:
it regulates splicing (enhancing or decreasing certain iso-
forms), regulates nonsense-mediated mRNA decay, has a
role on RNA metabolism (translation), RNA protein
binding, has a potential oncogenic role in cancer, regu-
lates the mitosis among other processes [9, 19–21]. We
have performed a differential expression analysis of this
experiment. We have included the main results in the
Additional file 1. The categories of gene ontology enriched
are concordant with the aforementioned functions
(Additional file 1).
Determining differential splicing events
An AS event is considered to be differentially spliced if
the concentration of the isoforms mapped to either
paths of the event (for example, in a cassette event the
path that skips and the path that includes the exon) are
differentially expressed in opposite directions (i.e. if one
of the isoforms is overexpressed, the other must be
underexpressed). For this particular experiment, the
contrast matrix compares the knock down samples using
siRNA with the samples of the cells transfected with
scramble siRNA. In the comparison of these two condi-
tions (with siRNA and with scramble siRNA), out of the
theoretical 70886 events, 3718 showed a p-value < 10-3
(approx. 5 % of the events).
Each of the paths in an event (the word path is used here
to refer to any of the two configurations of each event; see
Figs. 1 and 2, in a cassette event one path skips the exon
and the other one includes it) is annotated with the do-
mains (if any) included in the Ensembl database. In some
cases, the domain is disrupted in one of the paths com-
pared with the other. We performed a statistical analysis
of the enrichment of the domains that may affected by the
AS events. The statistics of this analysis are described in
the Methods section. In brief, we performed a Wilcoxon
test between the isoforms that contain a domain. The re-
sults of this analysis are summarized in Table 1.
The enrichment analysis illustrates one of the poten-
tials of this analysis. The laminins are proteins of the
extracellular matrix. The modification of their domains
is known to induce a pro-invasive phenotype [22].
Fig. 4 Number of detectable events by EventPointer. Number of AS events detected in each event type for HTA 2.0 and HJAY arrays
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Several of the motifs are related to RNA binding: RNA
recognition motif (a.k.a. RRM, RBD, or RNP domain).
These results are coherent with the GO enrichment ana-
lysis (Additional files 1 and 2) in which several of the
enriched categories are related with RNA modification.
To our knowledge, the relation between SRSF1 and the
WD40 domain was unknown. The underlying common
function of all WD40-repeat proteins is the coordination
of multi-protein complex assemblies, where the repeating
units serve as a rigid scaffold for protein interactions [23].
In addition to this, the RNA domains are also targets of
PRPF8, another splicing factor. IBR, as well as WD40, do-
mains are related to ubiquitin ligase complexes [24].
We have included a few of the domains that were
underexpressed after the knock-down of SRSF1. It is im-
portant to point out that the statistical significance is
much smaller. An intriguing result is that the tRNA syn-
thetases domains are overexpressed and underexpressed
depending on their class.
Validation of EventPointer
We used standard PCR to validate the five top-ranked
AS events within each of the eight different types of
events (i.e. cassette, mutually-exclusive, complex etc). In
total, 40 different events were tested. Each event was
validated on two different samples. The events were
Table 1 Enrichment of domains in the list of AS events regulated by SRSF1
The domains are sorted by its statistical significance. If several domains share similar properties, are grouped into a single row. The upper part of the table shows
overexpressed domains. The second part of the table (divided by a thick line) shows underexpressed domains. The statistical significance was larger for
overexpressed than for underexpressed domains
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ranked according to their p-values. In turn, the p-value
represents the “differential opposite expression” of each
of the isoforms interrogated by an event. The statistical
significance of the events (and their ranking) was very
different across the different AS types. All the five top-
ranked “cassette” and “complex” events were within the
overall top-20 ranked events. In contrast, only one out
of the five top-ranked “alternative 3′ site” was found
within the top-150 ranked events and the top ranked
“mutually exclusive exons” was in position 500. These
results are summarized in Table 2.
The 17 top ranked events appeared within the top-5 of
any of the categories and were validated. In all of them
the validation was positive although, in a few cases, the
PCR-band analysis (using ImageJ) did not pass statistical
significance. In Fig. 5 we show some of the PCR results.
Additional file 3 shows the results for all the events. Pri-
mer sequences are also included in the additional mater-
ial (Additional file 4).
Comparison with other software
Affymetrix Transcriptome Analysis Console (TAC 3.0)
and AltAnalyze are the only available software to detect
alternative splicing events using HTA 2.0. The main fea-
tures from each of them are briefly explained below and
the comparison with EventPointer is discussed in the lat-
ter paragraphs.
TAC 3.0
The software from Affymetrix is publicly available for
download and provides the user with different tools to
go beyond simple differential gene expression analysis.
Some of the options are gene pathway networks, miRNA
and target gene interactions and alternative splicing
events identification. It works only in Windows operat-
ing system.
Given the corresponding cel files, the software auto-
matically runs the analysis based on the options pro-
vided by the user.
TAC uses Splicing Index (SI) [25] as a measure to de-
tect alternative splicing events. Briefly, the SI of a probe-
set compares two ratios:
SI ¼
Probeset n signal Cond: 1
Overall signal of the gene in Cond: 1
n o
Probeset n signal Cond: 2
Overall signal of the gene in Cond: 2
n o
If the SI is close to one, then the behavior of the pro-
beset is coherent with the behavior of the gene. If it is
much larger or much smaller than 1, then the probeset
signal may indicate the presence of alternative splicing.
TAC applies several filters based on expression levels
(adjustable by the user) prior to the calculation of the
splicing index for any given PSR (probe selection region,
Table 2 Top-ranked AS events regulated by SRSF1 and the result
of their validation
Ranking HGNC symbol Type Validation
1 MYCBP2 Complex Event OK
2 KIF23 Cassette Exon OK
3 AC024560.3 Cassette Exon OK
4 FBXO22 Cassette Exon OK
5 SRSF3 Complex Event ~
6 SUPT16H Alternative Last Exon OK
7 HMBOX1 Alternative First Exon OK
8 ACAD11 Complex Event OK
9 NCOR1 Cassette Exon OK
10 AUP1 Retained Intron OK
11 IFT27 Alternative Last Exon OK
12 GALNT10 Alternative Last Exon ~
13 PARD3 Alternative Last Exon ~
14 PRMT2 Complex Event OK
15 HORMAD1 Cassette Exon OK
16 ANAPC7 Alternative Last Exon OK
17 OGT Complex Event OK
23 MSL3 Alternative First Exon OK
26 NT5C Alternative 5′ OK
29 ALG2 Alternative First Exon OK
33 MSL3 Alternative First Exon OK
39 BAIAP2L1 Alternative First Exon OK
40 HIST1H2AC Alternative 5′ ~
44 DDX52 Retained Intron ~
71 TMEM214 Retained Intron ~
74 GABPB1 Alternative 5′ OK
77 EIF3B Retained Intron ~
101 LAMP1 Retained Intron ~
113 LMO7 Alternative 3′ OK
149 SCAMP3 Alternative 5′ X
226 UHRF2 Alternative 5′ X
355 COPS3 Alternative 3′ X
464 SLSC9A8 Alternative 3′ ~
473 FLNA Alternative 3′ X
480 C21orf58 Alternative 3′ OK
500 CALU Mutually Exclusive X
688 CCT6P1 Mutually Exclusive ~
844 ST20 Mutually Exclusive OK
1388 ACO2 Mutually Exclusive X
1956 KIAA0100 Mutually Exclusive X
The first column shows the ranking of the event in EventPointer according to the
p-value. The last column states if the validation was positive: a (OK) mark is
shown if the validation is significant in PCR, a (~) mark is shown if differences in
the PCR can be observed but the statistical significance is above 0.05. A (X) mark
is shown if the event was not validated either because there was no differential
splicing, no alternative splicing or no expression at all
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i.e. subexon) or junction. It also classifies (some) of the
events according to the standard categories (exon cas-
sette, intro retention, etc.). And, for the ones that are
classified, TAC includes a “splicing score” (SS). This
value is based on “how well the data fits into pre-defined
splicing patterns”. Besides, both “PSRs and their related
junctions all contribute to an event score” that is
bounded between 0 and 1 (from the TAC manual). No
additional information is provided on how this score is
computed or how the events are classified and can be
considered as an experimental method. Only around half
of the events are given a SS. In our case, 23/40 (57 %) of
the validated events included the SS.
We sorted all the events found by TAC according to
the absolute value of the logarithm of the SI (negative
values indicate the lack of the exon in the case samples).
Fig. 5 PCR validation of three sample genes predicted by EventPointer. The figure shows the loci in the genome according to Ensembl, the
location of the primers, the results of the PCR, and the relative usage of the isoforms determined by a pseudo-quantification of the PCR images
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See Additional file 5 with a list of top TAC predicted
events.
AltAnalyze
This is an open-source software developed in the Nathan
Salomonis lab at Cincinnati Children’s Hospital Medical
Center and the University of Cincinnati. This project
began in the laboratory of Bruce Conklin at the Glad-
stone Institutes.. It can be downloaded from their web-
page (http://www.altanalyze.org/) and it can be run in
different operating systems such as Windows, Mac OS
and Ubuntu. As stated by the developers: “requires no
advanced knowledge of bioinformatics programs or
scripting”.
The software enables analysis of data produced by
both conventional and splicing sensitive microarrays (e.g
exon and junction arrays) as well as RNA-Seq data and
the pipeline enables a complete analysis that includes
identification of alternative splicing events and differen-
tial expression as well as different functional annotations
of the genomic regions identified as alternatively spliced.
For the detection of alternative splicing events,
AltaAnalyze uses two different algorithms to measure
splicing events: Splicing Index (as in TAC) and ana-
lysis of splicing by isoform reprocity (ASPIRE). See
Additional file 5 with a list of top AltAnalyze predicted
events. AltAnalyze provides the user the option to set dif-
ferent threholds to filter genes and AS events depending
on the expression levels.
The ASPIRE algorithm is used when two probesets (A
and B) measure the exclusion and inclusion of an exon
respectively. It provides a score similar to a fold change,
bounded between -1 and 1, where negative values indi-
cate that the expression in the probeset (A or B) in ex-
perimental group is higher than the control group. A
single splicing event can have (and usually does) several
inclusion indexes per event. Each of them correspond to
the pairwise comparisons between the probesets that in-
clude and exclude the event respectively.
In order to identify an event as statistically significant,
AltAnalyze relies on three different values: ratio of inclu-
sion, ratio of exclusion and δI. The first ratios measure
the proportion of the inclusion or exclusion of an exon
with the mean expression of the whole gene. Both ratios
must be in opposite directions to continue the analysis.
The δI value measures the difference between both the
inclusion and exclusion ratios. As a default value, any
event must have a δI above 0.2. A detailed explanation
of the algorithm can be found in the AltAnalyze user
manual. EventPointer takes into account all the exons
and junctions involved in the alternative splicing event
to give its statistical significance. The results for Event-
Pointer are normalized using the probeset in the refer-
ence path and using the whole gene for AltAnalyze and
TAC. On the other side, TAC (using SI) and AltAnalyze
(using ASPIRE) provide up to 3 statistical values for each
event (skipping junction vs flanking junction 1, skipping
junction vs exon and skipping junctions vs flanking
junction 2). Both AltAnalyze and TAC are focused on
case–control studies. EventPointer can be applied to any
experimental design that can be described with a design
and a contrast matrix.
Using the “GRanges” R package [26], we matched the
events expressed and detected by the three algorithms
(EventPointer, AltAnalyze and TAC). As explained before,
an event detected by EventPointer can be matched to more
than one element of either TAC or Analyze, as a result we
kept the unique events that where matched in order to
create the Venn diagram depicted in Fig. 6. This diagram
shows the expressed events for all of them. These events
do not necessarily show differential usage of the variants.
As already mentioned, TAC provides a different SI for
each of the probesets that interrogate an event. We sum-
marized these values taking the most significant SI for each
event. Table 3 provides the ranking of the top ten events
detected by EventPointer in both AltAnalyze and TAC.
Some comparison examples of top-ranked events
The events that can be clustered into three groups:
events with high ranking in the three algorithms, events
Fig. 6 Venn diagram of common events identified by EventPointer,
AltAnalyze and TAC The diagram displays the total number of events
detected by each algorithm (in parenthesis) and the corresponding
values for the intersections
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with high ranking in EventPointer and low ranking in
AltAnalyze and TAC and, finally, events low ranked to
EventPointer and high ranked in the other two algo-
rithms. The compared events, displayed in TAC, are
shown in Fig. 7.
Within the first group, KIF23 was ranked 2nd, 11th and
3rd in EventPointer, AltAnalyze and TAC, respectively.
The corresponding statistical values in each algorithm are:
1.00e-58 (EventPointer pvalue), 0.5523 (ASPIRE δI) and
16.67 (TAC SI). The three methods identify this event as
high-ranked. Figure 7a shows the TAC window at the par-
ticular region for this event.
HMBOX1 is also an event identified as high-ranked by
the three algorithms. The corresponding rankings are
7th, 6th and 98th in EventPointer, AltAnalyze and TAC,
respectively. Even though the ranking in TAC is not as
low as in the other two methods, the PCR validation
confirms the alternative splicing event. Figure 7b shows
the TAC window for this event.
In the second group, NCOR1 was ranked 9th in Event-
Pointer while AltAnalyze and TAC rank the event in po-
sitions 365 and 5757, respectively. This event shows
either the highest SI or δI value when compared to the
other events found for the same gene. The event was
validated by PCR and shows a significant pvalue (5.69e–
38) in EventPointer. Figure 7c shows the event in TAC.
ACAD11 is ranked as the 8th event in EventPointer
while AltAnalyze and TAC rank the event in positions 396
and 3371, respectively. It shows a similar behavior as
NCOR1. Figure 7d displays TAC window for this event.
NAA50 was ranked 10926th,6th and 148th in Event-
Pointer, TAC and AltAnalyze, respectively. The reason is
that this event is backed up by only one junction probe-
set. Since EventPointer finds no coherence with the
other paths of the event, the ranking is low (Fig. 7e).
This event was validated using PCR. The PCR results
are included in the supplementary material (Additional
file 6). For this event, the ranking of the event using
TAC 3.0 and EventPointer are very different. The reason
is the difference on the underlying statistical tests:
EventPointer imposes that both isoforms (i.e. both bands
in the PCR) must change in opposite directions. In this
case, the weak isoform changes its expression (from not
being expressed at all to being weakly expressed). How-
ever, the most expressed isoform does not change its ex-
pression at all and therefore, its statistical significance is
low using the EventPointer test. The reason to imple-
ment this restriction is that this type of changes (one
isoform strongly expressed and a weak change in the
other) has a debatable biological implication. Neverthe-
less, the EventPointer test can also be changed to detect
this type of events. If this is done, for this particular case
the p.value is smaller than 1e–16 and therefore strongly
significant.
DNM2 (2595th, 26935th and 1781th in EventPointer,
TAC and AltAnalyze, respectively) is a mutually exclu-
sive exon event. Even though the ranking is not good in
EventPointer, it was validated by PCR (see Additional file
7). TAC shows that, although the change in expression
between both isoforms is not large, each of the paths has
different signs in the corresponding SI (Fig. 7d).
Discussion
We have presented a complete pipeline to detect AS
events using HJAY and HTA 2.0 arrays. The main ad-
vantages of this method over the Splicing Index or
ASPIRE are that: 1) it can be applied to any experimen-
tal design (by providing the corresponding design and
contrast matrices) and not only to case–control studies,
2) it exploits the redundancy of all the junction probes
involved in an alternative splicing event and 3) it labels
all the events according to the different categories. All
the suggested events can be validated using standard
PCR by construction.
EventPointer is event-focused instead of transcript-
focused [27, 28]. It estimates the statistical significance
Table 3 Ranking of the top-ranked events according to EventPointer and their ranking positions in the other algorithms (EP: EventPointer,
AA: AltAnalyze)
Gene Event type Genomic position EP AA TAC
MYCBP2 Complex Event 13:77673020-77695630 1 12 383
KIF23 Cassette Exon 15:69713986-69714774 2 11 3
AC024560.3 Cassette Exon 3:197348575-197350253 3 9 113
FBXO22 Cassette Exon 15:76196323-76205608 4 55 1392
SRSF3 Complex Event 6:36566626-36568967 5 2095 280
SUPT16H Alternative Last Exon 14:21837979-21852105 6 NA 1026
HMBOX1 Alternative First Exon 8:28902878-28904970 7 6 98
ACAD11 Complex Event 3:132297677-132298402 8 396 3371
NCOR1 Cassette Exon 17:16052765-16055312 9 365 5757
AUP1 Retained Intron 2:74754863-74755133 10 NA 10501
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Fig. 7 (See legend on next page.)
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of AS events without estimating the concentration of the
underlying transcripts. For each event, EventPointer iden-
tifies the type of event (cassette, alternative start site, alter-
native donor, etc.) and provides its statistical significance
according to the design and contrast matrices given by the
user. EventPointer also generates a graphical output using
IGV [29] to make the identification and validation of the
events easier.
There are, however, some events that cannot be identi-
fied with EventPointer. For example, a couple of iso-
forms with different transcription start sites in which
one of them is included in the other. These types of
events are also very difficult to detect using RNAseq or
PCR since there is no a specific sequence in the second
isoform to design a primer.
In this work, we consider that there is a differential spli-
cing event if the isoforms in the associated paths change
their expression in opposite directions. Although this stat-
istical test can miss some AS events, the selected events
have a clear change on their expression. These changes,
usually, have more biological relevance than other sub-
tler cases in which only one isoform – usually weakly
expressed- changes its expression across the conditions.
Once the Affymetrix CEL files are analyzed (i.e. back-
ground corrected, normalized, and summarized using
the standard procedures), the statistical analysis to detect
the AS events is very fast by using the limma package.
Using a standard Intel i5 processor, the analysis requires
about 10 s. The hardware requirements are modest (a
low-end desktop computer with 4GB of RAM is suffi-
cient). The whole enrichment analysis takes only frac-
tions of a second. This is an advantage compared to the
requirements on storage, computational power and
memory of RNA-seq analysis. In addition to that, the
proposed methodology is very reliable: only one false
positive was found within the top-200 tested events.
The validation rate is quite high. Our thought is that
the reasons for this are on the one hand EventPointer
gets a single statistics that combines the information
within all the probesets interrogating the event and, on
the other hand, uses a proper reference region for each
event: most of the methods select a number of probesets
(all of them, only the one of constitutive exons, core or
quasi-constitutive exons, etc.) that are used for all the
events in the gene. However, in our case, this reference
is different for each event.
One of the key parts of the analysis of alternative spli-
cing is to provide a biological interpretation of the
splicing events, i.e. what is the difference between the
isoforms expressed in a condition specific manner..
EventPointer provides the protein family domains that
are affected on each of the splicing events. It also per-
forms an enrichment analysis (event-based) to identify
which are the domains that are significantly over or un-
derused in the condition under study. Even though in its
present form, EventPointer only provides information on
the PFAM domains we are actively developing it and we
have some alpha versions of the software that provide
annotation for other domain databases such us Pirsf,
Superfamily, Smart, Prosite, or Interpro. In addition to
protein domains, there are other interesting biological
data that could be inferred. For example in [30], Ray et
al. identify the binding motifs of several hundreds of
RNA binding proteins and the potential binding sites in
the human genome. Using this information is possible to
predict which are the splicing factors that are driving the
differential usage of isoforms. Another potential im-
provement would be to identify miRNA binding sites
and check if the splicing pattern causes skipping these
binding sites and therefore, the corresponding miRNAs
may be no longer regulating the expressed isoforms.
This functionality is already offered by AltAnalyze and
we expect to include it in the near future. Finally, in its
present form, EventPointer works for the HJAY and the
HTA2 arrays. We are actively developing the annotation
to apply EventPointer to Mouse and Rat junction arrays
(MTA-1 and RTA-1).
EventPointer could be extended to RNA-seq by build-
ing up the corresponding splicing graph and, in fact, we
are currently working on this extension. AltAnalyze can
also be applied to RNAseq and has been used for ex-
ample in [31]. In order to apply EventPointer to RNAseq
data, the splicing graph must be constructed based on
the sequencing reads and/or the annotation (for micro-
arrays we only use the annotation since the sequences of
the probes are fixed). The statistics to perform the ana-
lysis must also be changed: instead of using a linear
model on the log of the data signal, other methods such
as voom [32], or edgeR [33] should be used to take into
account the discrete nature of the reads.
There is one potential advantage of EventPointer when
extending it to RNAseq experiments. In microarrays, the
affinities of the probes are difficult to predict and, usu-
ally, they are considered to be unknown. Any algorithm
(including EventPointer) get results by implicitly esti-
mating the affinities given the data. The role of affinities
(See figure on previous page.)
Fig. 7 TAC view of six of the compared events. In each of the panels, there are three representations of the splicing graph for each gene. The
first one represents the measured expression for each probeset (shown as filled rectangles, yellow: low expression, blue: high expression) in
samples treated with SRSF1, the second one represents the expression in the samples treated with scramble siRNA (same color code) and the
third one represents the splicing index for each probeset (red: overexpressed, green: underexpressed)
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in RNAseq is played by the length of the regions that
originated the reads (the length of the exon where they
came from, for example). EventPointer can be adapted
to use the length of these regions to perform the statis-
tics or leave them as unknown and guess them (as it
happens with the arrays). This second approach does not
require the general assumption of considering uniform
coverage of the reads (that is known not to be true).
Conclusions
We have developed EventPointer software to detect AS
events using Affymetrix arrays. It has a high validation
rate and shows its effectiveness to detect AS events
using Affymetrix splicing-sensitive arrays. In addition to
that, its connection with IGV makes it very convenient
to validate the results using PCR.
This technique can be used on its own, but also to
cross-validate RNA-seq experiments. In addition to that,
it provides a statistical analysis of the usage of protein
domains and provides a single statistic per event that, to
our knowledge, is a novel development for analysis at
the transcript/event level.
Methods
Sample preparation and PCR validation
Downregulation of SRSF1, expression analyses and micro-
array hybridization were done as previously described [9].
Samples from two independent experiments were used for
validation of splicing events by endpoint PCR. Briefly,
RNA was retro-transcribed using PrimeScript RT reagent
Kit (Takara). PCR was performed using PCR Master Mix
(Promega) using the following program: 94 °C 2 min;
30 cycles at 94 °C 30 s, 57 °C 30 s, 72 °C 30 s; and 72 °C
10 min. Primers used are shown in Additional file 4. The
PCR products were loaded in 2 % agarose gels and sepa-
rated for 40–60 min at 100–120 V. Pictures were taken in
a UV transilluminator and the densitometry of the bands
was analyzed using Fiji software [34].
Selection of the events
Mapping
The probes included in HTA 2.0 array from Affymetrix
are mapped against the human transcriptome (Ensembl
74) using Bowtie 2.0. Multimapping probes, those that
map against more than 3 genes, are removed since they
are considered to be non-informative. This mapping is
used to build the CDF file, i.e. to group the probes ac-
cording to sets of probes and according to the events
(for further information see Additional file 8).
Construction of the splicing graph
The Splicing Graph (SG) [35] is a directed graph used to
represent the structure of a gene (see Fig. 5a and b).
Here, nodes are denoted as subexons (contiguous region
of the genome that belong to the same set of transcripts)
and in the SG two nodes are connected by an edge if
both subexons are contiguous in at least one isoform.
Two additional nodes, start and end nodes, are added to
the graph and nodes in 5′ (3′) locus of any isoform are
connected to them.
The nodes of the SG are duplicated (a and b nodes are
used to represent each node) so that both exon and
junction probes are represented exclusively by edges in
the graph (Fig. 1c). Junction probes connect ‘b’ nodes
with ‘a’ nodes and probes mapped against exons connect
‘a’ nodes with ‘b’ nodes.
Pruning and recovering of the splice graph
The SGs (one per gene) are very complex and include
many edges not supported by any probe on the array.
The SG has been pruned to retain only edges with
probes mapped to them. In some cases there are edges
with no probes mapped to them to ensure the coherence
of the graph, i.e. (see Fig. 2 upper panel) any node of the
SG is connected with the start and end nodes. For ex-
ample, although there is no probe mapping against junc-
tion E7–E8, the edge from E7 to E8 is not removed to
ensure that E7 is connected with the end node. In the
contrary, there is no probe mapping against junctions
E3–E4 and E4–E5 nor exon E4, and thus they can be re-
moved without affecting the coherence of the SG. For
further analysis see Additional file 1.
Finding the splicing events
In this work, a Splicing Event is described as a triplet
{PR, P1, P2} of subgraphs. These subgraphs are com-
posed of sets of edges and nodes that share the following
characteristics: 1) the flow traversing any of the edges of
each triplet is identical, and 2) the flow traversing any
edge in PR is the sum of the flows traversing P1 and P2.
P1 is assigned to be the set of edges with the largest gen-
omic length in the transcriptome and P2 to the shortest
one (i.e. in a cassette event, P1 is the path that includes
the skipping exon). The detection of the events can be
automated using graph theory. The values of the fluxes
of all the edges are calculated ensuring that two flows
will not be equal by random. Then, the edges with com-
mon flow values are grouped in sets. And finally, triplets
of sets with one of its flows summing up the other two
are grouped together (subgraphs 1 and 2). These last cor-
respond to events. For further information, see Additional
file 1.
Labeling the type of splicing event
The splicing events can be classified into 7 major cat-
egories: cassette exons, alternative 3′donor site, alterna-
tive 5′donor site, intron retention, alternative last exon,
alternative first exon and mutually exclusive exons. Any
Romero et al. BMC Genomics  (2016) 17:467 Page 13 of 18
event not classified into these is considered to be a com-
plex event. The labelling of an event is carried out ac-
cording to the structure of the subgraph of the event
{PR, P1 and P2} (see Fig. 2 lower panel).
Summarizing the events
Each of the events is composed of a triplet of probesets:
the probes mapped to path 1, path 2 and the reference.
For a specific event, there are isoforms that are not
mapped to any of the paths in the event. However, if an
isoform hits the event then, by construction, the isoform
can be mapped to PR and only to either P1 or P2.
Within the analysis, we consider that the signal of a
probe on an Affymetrix array is the product of the affinity
of the probe and the sum of the concentrations of the iso-
forms interrogated by the probe. Therefore, if yij is the
logarithm of signal of the probe i in condition j then,
yij ¼ log Af f yiτj
 þ εij ¼ log Af f y1ð Þ þ log τj þ εij
ð1Þ
where Affyi is the affinity of the probe, τj is the sum of
the concentrations of the transcripts interrogated by
probe i, and εij is an error term.
In EventPointer (as in most other methods that use
Affymetrix technology), the values of the probe signals
within a probeset are summarized to a single value using
the median polish algorithm [36]. We have assumed that
the model for a single probe is also valid for the summa-
rized value of the probeset (i.e. the signal in the probeset
is proportional to the concentration of the isoforms in-
terrogated by the probeset).
Let us consider a differential splicing event that con-
sists of two alternative stop sites (i.e. transcript end), in-
terrogated by 6 probes. Probes 1 and 2 belong to PR,
Probes 3 and 4 to P1, and probes 5 and 6 to P2 (see
Fig. 8a). Let us assume that this event is measured in
two different conditions, normal (N) and tumor (T).
There will be 12 different measurements that, after
summarization, are converted to the 6 values yRN, y1N,
y2N, yRT, y1T, y2T that correspond to the summarized sig-
nals of PR, P1 and P2 in the normal and tumor samples,
Fig. 8 Steps of the statistical Analysis: a toy example, a The intensity values are summarized per path and sample, b the Design and Contrast
matrices defined by the user are extended and (c) the linear model is solved to obtain the values of the coefficients and the statistical significance is
determined using Limma package
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respectively (see Fig. 8a). For this example, the signal
yRN -dropping the error terms- (i.e. the probeset in the
reference path in the normal sample that comprises
probes 1 and 2) is
yRN ¼ log Af f yR t1N þ t1Nð Þð Þ ¼ log Af f yRð Þ þ log t1N þ t2Nð Þ
ð2Þ
The signal of y2T (probeset P2 –probes 5 and 6- in the
tumor sample), we have,
y2T ¼ log Af f y2ð Þ þ log t2Tð Þ ð3Þ
Since the probeset resides in path 2, it only measures
the second isoform.
Construction of the design matrix for alternative splicing
detection
A convenient formalism to describe an experiment is
using the contrast and design matrices. This section de-
scribes how to build these matrices to detect differential
splicing events.









Its usefulness will be shown later. Let D be the design
matrix of the experiment. The proposed design matrix
DDRS to detect splicing events is:
DDRS ¼ D⊗Q½ ; ð5Þ
where ⊗ is the matrix Kronecker product. We have in-
cluded a simple example to illustrate the concepts. The
corresponding design (D) and extended design matrices
(D⊗Q) for the aforementioned example are shown in
Fig. 6b. The design matrix includes an intercept term for
all the samples and an increment for the tumor sample. If
this experiment only studied gene expression, the contrast
matrix would simply test if the increment of expression in
the tumor samples is different from zero. The Kronecker
product is equivalent to replacing each of the entries of
matrix D, by matrix Q multiplied by the corresponding







































Using some algebra, it is possible to get the value of
the coefficients (Table 4).
Within Table 4, there are some coefficients that in-
volve affinities and, therefore, have little interest from a
biological point of view. The first 6 rows provide the
values of the β0 to β5. Rows 8 to 9 provide the values of
linear combinations that have interest to detect splicing.
There are a number of alternatives to detect AS using
these coefficients. Either of β4, β5, β4+ β5 is theoretically
able to detect AS events. Some of them are more sensi-
tive than others depending on the relative concentra-
tions of the isoforms. For example, if isoform 2 is much
more highly expressed than isoform 1 in both condi-
tions, β4 will be more sensitive than β4+ β5 since in the
latter case, the numerator and denominator of the loga-
rithms of both terms are similar, and hence their logs
are close to zero. A contrast on β5 would seem to be
more sensitive than a contrast on β4 or β4+ β5; however,
in practice, this contrast proved to be “too sensitive” and
led to many false positives especially in weakly expressed
isoforms. If one of the paths is not expressed in any con-
dition, its signal will be similar in either condition (the
background level) and a change in the expression of the
other isoform will drive to a false positive detection. This
contrast can be used only if the signals are filtered to
guarantee that they are above the background.
Table 4 Values of the factors for the lineal model and their interpretation
Value of Beta Interpretation
β0 = log(AffR) + log(t1N + t2N) No special interest










β3 ¼ log t1Tþt2Tt1Nþt2N
 
Logarithm of the overall fold change of the event. Differential expression present if different from zero.




Difference of the logarithms of the fold change using relative concentrations of isoform 1 in both conditions.
AS present if different from 0.




Difference of the logarithms of the fold change of both isoforms. AS present if different from zero.




Difference of the logarithms of the fold change using relative concentrations of isoform 2 in both conditions.
AS present if different from 0.
β3 þ β4 ¼ log t1Tt1N
 
Logarithm of the fold change of isoform 1.
β3 þ β4 þ β5 ¼ log t2Tt2N
 
Logarithm of the fold change of isoform 2.
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In the PCR validation, the contrast that provided the
best performance was the combination of the fold
changes of both isoforms (i.e. β3 + β4 and β3 + β4 + β5 in
Table 4) plus the requirement that the fold-changes have
opposite directions, i.e. if isoform 1 significantly in-
creases its expression, isoform 2 must significantly de-
crease its expression and visa versa. Therefore, if this
test requires that the detected AS events show a signifi-
cant change of the expression both paths and this
change must be in opposite direction.
In order to compute this contrast, we summed up the
p-values (one-tailed) for both contrasts. If the null hy-
pothesis holds, the expected null distribution is triangu-
lar from 0 to 2 with the peak at 1, and the summation of
the p-values must be close to 0 or close to 2 for genes
with differential AS. Using this triangular distribution, it
is possible to assign an overall p-value to their sum. We
preferred this combination rather than the classical
Fisher method since in the latter a single good p-value
yields a good summary p-value for the event. Using this
approach, both p-values must be close to zero or one in
order to generate a significant overall p-value.
All the statistics had been implemented in an R pack-
age (available at Github), which depends on the limma
method to get the statistical significance. Given the
“standard” design matrix, D and the corresponding con-
trast matrix C, the software internally computes the de-
sign and contrast matrices of the events DDRS and CDRS.
Moreover, given a contrast matrix for the experiment, the
contrast matrix to detect the splicing events is given by:
CDRS ¼ C⊗ 1 1 0½ C⊗ 1 1 1½ 
 
; ð7Þ
in where each row represents the constrasts β3+β4 and
β3+β4+ β5 i.e. for each given contrast, the differential
usage of both pathways is tested and summarized.
By construction, each contrast is split into two differ-
ent contrasts (to test the differential expression of both
isoforms) and afterwards, they are summarized and
returned to the user.
Expression filter
The contrast previously described is very sensitive. If
one of the paths of an event is not expressed and the
other one is, EventPointer would assign a significant p-
value to the event. This would result in a large number
of false positives due to the lack of expression.
In order to avoid this problem, EventPointer allows
the user to filter the events to ensure that all the paths
are expressed above a fixed threshold. For every path,
the algorithm gets the maximum value of expression
from all the samples. The maximum values for the
references are used to set the threshold. The user pro-
vides a quantile that will set the threshold.
Once the threshold is selected, an event will be consid-
ered as expressed if the maximum value of expression
for all the paths is above the threshold previously set.
Domain expression analysis
Using the Ensembl database is possible to relate each of
the paths P1 and P2 in the events with the presence of
protein domains within them. For each domain, it is
possible to know in which paths P1 and P2 is included.
In order to state the statistical significance of the events,
we performed a Wilcoxon test paired for each event (P1
and P2). This algorithm is done using sparse matrices
and turns to be very efficient (less than 1/10th of second
for all the domains in the Pfam database).
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